ArticleAnimal models and experimental medicine2026
Establishment of a chronic aspiration pneumonia mouse model using oropharyngeal aspiration of food suspension.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAspiration pneumonia (AP) is a prevalent and life-threatening pulmonary disease resulting from repeated aspiration of exogenous materials such as food or gastric contents. However, most existing animal models simulate only acute injury and fail to reproduce the chronic pathological features observed in patients. This study aimed to establish a stable and clinically relevant chronic AP mouse model.
methodsFirst, four inhalation techniques including unilateral vagotomy (UV), intranasal inoculation (IN), intratracheal instillation (IT), and oropharyngeal aspiration (OA) were evaluated for model establishment in mice. The optimal method OA was applied to administer normal saline (NS), food suspension (FS), or gastric contents (GC) once weekly. Disease progression was evaluated at 2, 4, and 8 weeks. Lung injury was evaluated by tracer distribution, histopathology, cytokine profiling, transcriptomic analysis, and micro-computed tomography (micro-CT).
resultsOA achieved stable pulmonary delivery. Both FS and GC induced lung injury. However, 8-week FS exposure resulted in more severe and persistent damage, characterized by increased alveolar-capillary barrier permeability and elevated cytokine and chemokine levels. Histology showed FS-specific obstructive bronchiolitis with retained food particles, closely mimicking human aspiration pneumonia. Micro-CT revealed gravity-dependent pulmonary consolidation, most evident in the FS group. Transcriptomic analysis indicated activation of neutrophil extracellular traps (NETs) formation during chronic AP progression.
conclusionsThis OA-based FS model reproduced the key pathological and imaging features of human chronic AP and implicated NETs in the disease progression. It provides a robust platform for mechanistic investigation and therapeutic development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.